Morris v. Parke, Davis & Co.

573 F. Supp. 1324, 1983 U.S. Dist. LEXIS 13718
CourtDistrict Court, C.D. California
DecidedSeptember 15, 1983
DocketCV 82-5296-RJK (JRx)
StatusPublished
Cited by5 cases

This text of 573 F. Supp. 1324 (Morris v. Parke, Davis & Co.) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Morris v. Parke, Davis & Co., 573 F. Supp. 1324, 1983 U.S. Dist. LEXIS 13718 (C.D. Cal. 1983).

Opinion

OPINION

KELLEHER, Senior District Judge.

This action arises out of personal injuries that plaintiff David Morris allegedly suffered in reaction to a diphtheria, pertussis and tetanus (DPT) vaccine. The vaccine was administered to him in June of 1965, when he was six months old. Since that time, David Morris has suffered from irreversible brain damage. Joined as plaintiffs are David’s parents, Lesta Morris and Eddie Morris. Defendants are five pharmaceutical companies that allegedly manufac *1325 tured a substantial share of the DPT on the market at the time of David Morris’ injury.

Plaintiffs seek to recover damages on five causes of action. The first four are standard products liability claims — negligence, express warranty, implied warranty, and strict liability. The fifth states a claim for concert of action. Federal jurisdiction is invoked on the basis of diversity of citizenship.

Plaintiffs concede that they are unable to identify the manufacturer of the vaccine actually administered to David Morris. The vaccine apparently was marketed under the generic name DPT; plaintiffs do not know, and indeed have no way to discover, who manufactured the DPT vaccine that caused the alleged injury. By bringing this action against companies that manufactured a substantial share of the DPT on the market at the time of David’s injury, plaintiffs rely upon the “market share” theory expounded in Sindell v. Abbott Laboratories, 26 Cal.3d 588, 607 P.2d 924, 163 Cal.Rptr. 132 (1980). In that case, plaintiff brought a class action against manufacturers of the drug diethylstilbesterol (DES). Plaintiff’s mother had taken DES while pregnant, exposing plaintiff to the drug prior to birth. The DES allegedly caused plaintiff to develop adenosis, a deadly disease, many years later. As in the instant case, plaintiff could not identify the manufacturer of the drug that caused her injuries. Nonetheless, the California Supreme Court held that plaintiff had stated a valid claim. If plaintiff could show that DES had caused her illness, and could further establish that defendants had produced a substantial percentage of the DES on the market when her mother ingested the drug, the burden of proof would then shift to defendants to prove that they could not have made the substance that injured plaintiff. 24 Cal.3d at 612, 607 P.2d at 937, 163 Cal.Rptr. at 145. Each defendant unable to sustain that burden would be held liable for the proportion of the judgment represented by its share of the market. Id.

Sindell marked an important departure from the traditional concept of causation. While the plaintiff would still be required to trace her injuries to a specific product, she would not have to trace the product itself to a specific manufacturer. Rather, she could recover from every defendant who had introduced the offending substance into the marketplace, with each such defendant bearing liability in an amount corresponding to the likelihood that it had caused plaintiff’s injuries.

Plaintiffs commenced the instant action on October 12, 1982, seeking both compensatory and punitive damages. In February of 1983, all five defendants joined in motions to strike the prayer for punitive damages. The motions were heard on April 4, 1983- Ruling from the bench, the Court denied defendants’ motions to strike. Because these motions raised questions of first impression, the Court takes this opportunity to set forth the reasons for its decision.

A. Introduction

In moving to strike plaintiffs’ prayer for punitive damages, defendants contend that plaintiffs are precluded from such recovery as a matter of law. They argue that the Sindell rule allows compensatory damages, but that it cannot support the recovery of punitive damages no matter how egregious defendants’ conduct is proven to be. The Court finds this view to be overstated. Although plaintiffs must carry a heavy burden in order to recover punitive damages, it cannot be said that they are absolutely foreclosed from such recovery. If plaintiffs are able to establish that their injuries were caused by DPT, and can further show that one or more of the defendants marketed the drug with conscious disregard the health of consumers, they will be entitled to recover punitive damages from each such defendant. This view is not only consistent with Sindell, but also comports with the venerable line of authority recognizing that punitive damages are an indispensable deterrent to conduct that would endanger the public health.

Punitive damages have long been imposed upon tortfeasors whose actions are *1326 deemed to be particularly nefarious. 1 In California this rule is embodied in section 3294 of the Civil Code, 2 which allows plaintiffs to recover exemplary damages from defendants who act with malice. 3 The statute defines malice as “conduct which is intended by the defendant to cause injury to the plaintiff or conduct which is carried on by the defendant with a conscious disregard of the rights or safety of others.” Cal.Civ.Code § 3294(c)(1) (West Supp.1983).

In the instant case, plaintiffs do not allege that the defendants intended to cause David Morris’ injury. They do allege, however, that defendants marketed DPT with conscious disregard of the safety of consumers. Accepting this allegation as true, as we must on defendants’ motion to strike, the Court finds that plaintiffs’ prayer for punitive damages is facially consistent with California’s statutory scheme. This finding does not end our inquiry, however. The question of whether punitive damages may be awarded in a Sindell case raises problems both intricate and novel. In order to resolve these problems, the Court must look to the decisional law concerning both punitive damages and products liability, and then determine how these doctrines apply in actions brought under the theory of Sindell.

B. Punitive Damages: Function and Purpose

Of the numerous functions commonly attributed to punitive damages, the two most frequently named are punishment and deterrence. “The primary purposes of punitive damages are punishment and deterrence of like conduct by the wrongdoer and others.” Grimshaw v. Ford Motor Co., 119 Cal.App.3d 757, 810, 174 Cal.Rptr. 348, 382 (1981). See also Owen, supra note 1, at 1277-87. Punitive damages are thus one means by which society seeks to control injurious behavior that grossly violates accepted norms.

Commentators have suggested at least two secondary justifications for awarding punitive damages:

First, they induce private persons to enforce the rules of law by rewarding them for bringing malefactors to justice.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Grano v. Sodexo, Inc.
S.D. California, 2020
Smith v. Eli Lilly & Co.
527 N.E.2d 333 (Appellate Court of Illinois, 1988)
Shackil v. Lederle Laboratories
530 A.2d 1287 (New Jersey Superior Court App Division, 1987)
Magallanes v. Superior Court
167 Cal. App. 3d 878 (California Court of Appeal, 1985)

Cite This Page — Counsel Stack

Bluebook (online)
573 F. Supp. 1324, 1983 U.S. Dist. LEXIS 13718, Counsel Stack Legal Research, https://law.counselstack.com/opinion/morris-v-parke-davis-co-cacd-1983.